ArticleThe Journal of international medical research2026
The Trojan horse of off-label glucagon-like peptide-1 receptor agonist use: Protecting patients through responsible practice.
Andrej Belančić et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.